Alterity Therapeutics Limited Stock
Stocks
ATH
AU0000043945
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5600 AUD | -1.75% |
|
-6.67% | +40.00% |
| Market Cap | 84.1M 73.74M 67.97M 63.64M 119M 7.93B 122M 817M 316M 3.92B 316M 309M 13.6B | P/E 2026 * |
-0.22x | P/E 2027 * | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 38.91M 34.12M 31.45M 29.44M 55.21M 3.67B 56.36M 378M 146M 1.81B 146M 143M 6.29B | EV / Sales 2026 * |
11.4x | EV / Sales 2027 * | 27x |
| Free-Float |
91.47% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alterity Therapeutics Limited
| 1 day | -1.75% | ||
| 1 week | -6.67% | ||
| Current month | +24.44% | ||
| 1 month | +24.44% | ||
| 3 months | +60.00% | ||
| 6 months | +31.76% | ||
| Current year | +40.00% |
| 1 week | 0.56 |  | 0.6 |
| 1 month | 0.4 | | 0.6 |
| Current year | 0.35 | | 0.6 |
| 1 year | 0.35 | | 0.85 |
| 3 years | 0.1 | | 0.95 |
| 5 years | 0.1 | | 2.1 |
| 10 years | 0.1 | | 20.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 07/01/2021 |
Abby Niven
DFI | Director of Finance/CFO | - | 30/09/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 29/07/2005 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 08/08/2011 |
David Stamler
BRD | Director/Board Member | 65 | 21/11/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-15 | Free | Chairman | 2,000,000 | 0.0184% | ||
| 06-15 | Free | Director | 1,000,000 | 0.0092% | ||
| 06-15 | Free | Director | 1,000,000 | 0.0092% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.75% | -6.67% | +24.44% | +86.67% | 84.1M | |
| -0.48% | +7.20% | -5.08% | +2.45% | 46.2B | |
| +2.19% | +11.71% | +385.81% | +632.13% | 38.71B | |
| +2.53% | +13.93% | +20.85% | -10.61% | 31.9B | |
| +1.65% | +3.61% | +9.98% | +55.42% | 31.12B | |
| -4.16% | -2.58% | +8.74% | +15.22% | 23.77B | |
| -0.32% | +12.96% | - | - | 16.2B | |
| +1.37% | +14.53% | +71.80% | +134.14% | 15.05B | |
| +1.00% | +10.30% | +13.31% | +22.84% | 13.74B | |
| +3.63% | +9.53% | +104.07% | +107.62% | 13.42B | |
| Average | +0.57% | +7.56% | +70.44% | +116.21% | 23.02B | |
| Weighted average by Cap. | +0.75% | +8.70% | +86.66% | +140.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.42M 3M 2.77M 2.59M 4.86M 323M 4.96M 33.27M 12.87M 160M 12.86M 12.58M 554M | 1.6M 1.4M 1.29M 1.21M 2.27M 151M 2.32M 15.55M 6.02M 74.61M 6.01M 5.88M 259M |
| Net income | -13.44M -11.79M -10.86M -10.17M -19.07M -1.27B -19.47M -131M -50.53M -627M -50.47M -49.37M -2.17B | -22.29M -19.54M -18.01M -16.87M -31.63M -2.1B -32.28M -217M -83.78M -1.04B -83.7M -81.87M -3.6B |
| Net Debt | -45.19M -39.62M -36.52M -34.19M -64.12M -4.26B -65.45M -439M -170M -2.11B -170M -166M -7.31B | -40.88M -35.84M -33.04M -30.93M -58M -3.86B -59.21M -397M -154M -1.91B -154M -150M -6.61B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/26 | A$0.5600 | -1.75% | 120,362 |
| 25/06/26 | A$0.5700 | -0.87% | 421,846 |
| 24/06/26 | A$0.5750 | +2.68% | 155,361 |
| 23/06/26 | A$0.5600 | -5.08% | 316,642 |
| 22/06/26 | A$0.5900 | -1.67% | 166,242 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
Select your edition
All financial news and data tailored to specific country editions
